Correlation Between NLS Pharmaceutics and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NLS Pharmaceutics AG and Larimar Therapeutics, you can compare the effects of market volatilities on NLS Pharmaceutics and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and Larimar Therapeutics.
Diversification Opportunities for NLS Pharmaceutics and Larimar Therapeutics
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between NLS and Larimar is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between NLS Pharmaceutics and Larimar Therapeutics
Assuming the 90 days horizon NLS Pharmaceutics AG is expected to generate 4.73 times more return on investment than Larimar Therapeutics. However, NLS Pharmaceutics is 4.73 times more volatile than Larimar Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about -0.3 per unit of risk. If you would invest 1.40 in NLS Pharmaceutics AG on September 13, 2024 and sell it today you would lose (0.31) from holding NLS Pharmaceutics AG or give up 22.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NLS Pharmaceutics AG vs. Larimar Therapeutics
Performance |
| Timeline |
| NLS Pharmaceutics |
| Larimar Therapeutics |
NLS Pharmaceutics and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NLS Pharmaceutics and Larimar Therapeutics
The main advantage of trading using opposite NLS Pharmaceutics and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.| NLS Pharmaceutics vs. Reviva Pharmaceuticals Holdings | NLS Pharmaceutics vs. GeoVax Labs | NLS Pharmaceutics vs. NLS Pharmaceutics AG | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |